A new blood test pioneered by diagnostics company AOA Dx (AOA) can detect ovarian cancer in symptomatic women with high ...

Two studies led by Johns Hopkins Kimmel Cancer Center, Ludwig Center, and Johns Hopkins Whiting School of Engineering ...

Deep inside the body, a slow-growing cluster of mutated blood cells can form. This cluster, found in 1 in 5 older adults, can ...

Recent breakthroughs in artificial intelligence and metabolite biomarkers enable cancer detection from just a drop of dried blood with up to 100% accuracy for some deadly cancers like pancreatic and ...

Researchers at Johns Hopkins University have discovered that specific blood tests can be used for the early detection of cancer. These tests can identify and diagnose cancer up to three years ...

A national pilot study designed to determine if blood tests can help detect cancers earlier is open for enrollment.Results of the Vanguard Study — which will include up to 24,000 people ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD ...

Doctors at Allegheny Health Network are hailing a groundbreaking study as a “game-changer” in cancer detection.

Want to B-positive about your health? Johns Hopkins researchers have developed a cutting-edge blood test that can detect signs of cancer three years before any symptoms surface.

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with low-grade serous ovarian cancer (LGSOC), according to a study.